• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AUR
Click for more information
0.00% 0.5¢

AURIS MINERALS LIMITED - News & Media

Market Cap $2.383M  ! watchlist Created with Sketch. Add to my watchlist
Metals & Mining Industrial Metals & Minerals

Auris Minerals Limited is exploring for copper and gold in the Bryah Basin, Western... Auris Minerals Limited is exploring for copper and gold in the Bryah Basin, Western Australia. Its projects include Morck Well, Doolgunna and Forrest. The Morck Well Project is located around 100 kilometers (Kms) north of Meekatharra and 20 Kms to the southwest of the DeGrussa Copper/Gold mine. The Morck Well Project prospects include McLean Well Base Metal/Manganese Prospect, Jacques East Gold Prospect, Frenchy's South Gold Prospect and Durack East Gold Prospect. The Morck Well Project tenements E51/1033, E52/1613 and E52/1672 has outside interests: the Company (80%) and CuFe Ltd (20%). The Doolgunna Project tenement includes E52/2438. The Forrest Project is located six kms south along strike from Westgold's Starlight VHMS intersection, comprising equivalent stratigraphic position to Horseshoe Lights copper-gold deposit. The Forrest Project tenements include E52/1659, E52/1671 and E52/4236. It has a consolidated tenement portfolio of over 391 square kilometers in copper gold basin.More

No News & Media currently available.

(20min delay)
Last
0.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $2.383M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
5 2191758 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 615455 4
View Market Depth
Last trade - 09.59am 02/10/2024 (20 minute delay) ?
AUR (ASX) Chart

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
PainChek close to finding out if FDA approves its flagship app for use in dementia care PainChek (ASX:PCK) has updated the market on the progress of its De Novo submission to the US FDA for its flagship app in aged care settings.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t Maximus Resources (ASX:MXR) has unveiled its latest drilling assay results at Eagles Nest, hitting gold downhole multiple assets.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.